BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35084794)

  • 1. A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS-CoV-2 Variants of Concern.
    Zhang Z; Li J; Gu J; Amini R; Stacey HD; Ang JC; White D; Filipe CDM; Mossman K; Miller MS; Salena BJ; Yamamura D; Sen P; Soleymani L; Brennan JD; Li Y
    Chemistry; 2022 Mar; 28(15):e202200078. PubMed ID: 35084794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.
    Li J; Zhang Z; Gu J; Stacey HD; Ang JC; Capretta A; Filipe CDM; Mossman KL; Balion C; Salena BJ; Yamamura D; Soleymani L; Miller MS; Brennan JD; Li Y
    Nucleic Acids Res; 2021 Jul; 49(13):7267-7279. PubMed ID: 34232998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A universal DNA aptamer as an efficient inhibitor against spike-protein/hACE2 interactions.
    Silwal AP; Jahan R; Thennakoon SKS; Arya SP; Postema RM; Vander Ark EC; Tan X
    Chem Commun (Camb); 2022 Jul; 58(58):8049-8052. PubMed ID: 35748608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One Solution for All: Searching for Universal Aptamers for Constantly Mutating Spike Proteins of SARS-CoV-2.
    Li J; Zhang Z; Amini R; Li Y
    ChemMedChem; 2022 Jul; 17(13):e202200166. PubMed ID: 35491395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach.
    Silwal AP; Thennakoon SKS; Arya SP; Postema RM; Jahan R; Phuoc CMT; Tan X
    Theranostics; 2022; 12(12):5522-5536. PubMed ID: 35910791
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA aptamer selection for SARS-CoV-2 spike glycoprotein detection.
    Martínez-Roque MA; Franco-Urquijo PA; García-Velásquez VM; Choukeife M; Mayer G; Molina-Ramírez SR; Figueroa-Miranda G; Mayer D; Alvarez-Salas LM
    Anal Biochem; 2022 May; 645():114633. PubMed ID: 35247355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RaptGen-Assisted Generation of an RNA/DNA Hybrid Aptamer against SARS-CoV-2 Spike Protein.
    Adachi T; Nakamura S; Michishita A; Kawahara D; Yamamoto M; Hamada M; Nakamura Y
    Biochemistry; 2024 Apr; 63(7):906-912. PubMed ID: 38457656
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Chen Y; Yang X; Liu J; Zhang D; He J; Tang L; Li J; Xiang Q
    Nucleosides Nucleotides Nucleic Acids; 2023; 42(2):105-118. PubMed ID: 35949145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry.
    Valero J; Civit L; Dupont DM; Selnihhin D; Reinert LS; Idorn M; Israels BA; Bednarz AM; Bus C; Asbach B; Peterhoff D; Pedersen FS; Birkedal V; Wagner R; Paludan SR; Kjems J
    Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34876524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three on Three: Universal and High-Affinity Molecular Recognition of the Symmetric Homotrimeric Spike Protein of SARS-CoV-2 with a Symmetric Homotrimeric Aptamer.
    Li J; Zhang Z; Gu J; Amini R; Mansfield AG; Xia J; White D; Stacey HD; Ang JC; Panesar G; Capretta A; Filipe CDM; Mossman K; Salena BJ; Gubbay JB; Balion C; Soleymani L; Miller MS; Yamamura D; Brennan JD; Li Y
    J Am Chem Soc; 2022 Dec; 144(51):23465-23473. PubMed ID: 36520671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study.
    Saify Nabiabad H; Amini M; Demirdas S
    Chem Biol Drug Des; 2022 Feb; 99(2):233-246. PubMed ID: 34714580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proof-of-concept for speedy development of rapid and simple at-home method for potential diagnosis of early COVID-19 mutant infections using nanogold and aptamer.
    Ellipilli S; Wang H; Lee WJ; Shu D; Guo P
    Nanomedicine; 2022 Sep; 45():102590. PubMed ID: 35905841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Affinity Dimeric Aptamers Enable the Rapid Electrochemical Detection of Wild-Type and B.1.1.7 SARS-CoV-2 in Unprocessed Saliva.
    Zhang Z; Pandey R; Li J; Gu J; White D; Stacey HD; Ang JC; Steinberg CJ; Capretta A; Filipe CDM; Mossman K; Balion C; Miller MS; Salena BJ; Yamamura D; Soleymani L; Brennan JD; Li Y
    Angew Chem Int Ed Engl; 2021 Nov; 60(45):24266-24274. PubMed ID: 34464491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
    Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
    J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-sensitive label-free SERS biosensor with high-throughput screened DNA aptamer for universal detection of SARS-CoV-2 variants from clinical samples.
    Park KS; Choi A; Kim HJ; Park I; Eom MS; Yeo SG; Son RG; Park TI; Lee G; Soh HT; Hong Y; Pack SP
    Biosens Bioelectron; 2023 May; 228():115202. PubMed ID: 36940632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and Characterization of Spike N-Terminal Domain-Binding Aptamers for Rapid SARS-CoV-2 Detection.
    Kacherovsky N; Yang LF; Dang HV; Cheng EL; Cardle II; Walls AC; McCallum M; Sellers DL; DiMaio F; Salipante SJ; Corti D; Veesler D; Pun SH
    Angew Chem Int Ed Engl; 2021 Sep; 60(39):21211-21215. PubMed ID: 34328683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study.
    Devi A; Chaitanya NSN
    Mol Divers; 2022 Feb; 26(1):157-169. PubMed ID: 33389440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.